Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )

NCT04863079 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

82

Enrollment

OTHER

Sponsor class

Conditions

ESCC
Adjuvant Treatment
Lymph Node Positive
Pembrolizumab

Interventions

DRUG: Pembrolizumab Injection [Keytruda]

Sponsor

Tianjin Medical University Cancer Institute and Hospital